Penumbra

Penumbra Inc is an equity in the USA market. The price is 251.06 USD currently with a change of 0.90 USD (0.00%) from the previous close. The latest open price was 251.76 USD and the intraday volume is 233,847. The intraday high is 252.34 USD and the intraday low is 249.08 USD. The latest trade time is Thursday, July 3, 14:19:00 PDT.

Penumbra, Inc. is a global healthcare company specializing in the design, development, manufacturing, and marketing of innovative medical devices aimed at addressing complex medical conditions with significant unmet needs.

Founded in 2004 and headquartered in Alameda, California, Penumbra has expanded its reach to over 100 markets worldwide, employing more than 4,500 individuals.

Product Portfolio

The company's product portfolio focuses on neuro and vascular interventional therapies. They offer solutions for conditions such as:

• Acute ischemic stroke
• Brain aneurysms
• Acute limb ischemia
• Deep vein thrombosis
• Neurovascular malformations

Their offerings include:

• Neurovascular Access Systems facilitating delivery of therapeutic devices to targeted brain areas.
• Revascularization Devices designed to restore blood flow in occluded vessels.
• Embolization Coiling Systems providing minimally invasive treatment for aneurysms and vascular lesions.
• Microcatheters used to navigate complex vascular pathways for precise delivery of therapies.

Innovations and Technology

Penumbra is committed to innovation, exemplified by the development of the REAL System. This immersive 3D computer-based technology platform enhances training and performance of healthcare professionals in interventional procedures. It offers realistic simulations to refine skills and improve patient outcomes.

Global Presence

Penumbra operates globally, with offices and facilities in numerous countries. These include:

• United States (headquartered at 1310 Harbor Bay Parkway, Alameda, California, 94502)
• Brazil
• Germany
• Australia
• Canada
• Singapore
• France
• United Kingdom
• San Francisco, CA, USA

Company Commitment

Penumbra's dedication to advancing patient care through innovative therapies underscores its leadership in the medical device industry. The company continually strives to meet the evolving needs of healthcare providers and patients worldwide.